4.2 Review

HIV and comorbidities - the importance of gut inflammation and the kynurenine pathway

期刊

CURRENT OPINION IN HIV AND AIDS
卷 18, 期 2, 页码 102-110

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/COH.0000000000000782

关键词

dysbiosis; geroscience; HIV; kynurenine; microbiome; microbiota; senotherapeutics

向作者/读者索取更多资源

The article reviews alterations in microbiota composition, diversity, and functional features in relation to chronic inflammation and comorbidities associated with HIV infection. The gut microbiome plays a crucial role in host immunity, and disruption of gut homeostasis can lead to systemic inflammation and immune activation. Ageing and HIV share similar features of intestinal damage and changes in bacterial composition, contributing to a proinflammatory state and age-related comorbidities. The nicotinamide adenine dinucleotide (NAD+)-producing kynurenine pathway (KP) is explored as a potential inflammatory pathway involved in metabolic changes and age-related diseases in PWH.
Purpose of reviewThe purpose of this article is to review alterations in microbiota composition, diversity, and functional features in the context of chronic inflammation and comorbidities associated with HIV infection.Recent findingsThe gut microbiome is an important mediator of host immunity, and disruption of gut homeostasis can contribute to both systemic inflammation and immune activation. Ageing and HIV share features of intestinal damage, microbial translocation and alterations in bacterial composition that contribute to a proinflammatory state and development of age-related comorbidities. One such inflammatory pathway reviewed is the nicotinamide adenine dinucleotide (NAD+) producing kynurenine pathway (KP). Kynurenine metabolites regulate many biological processes including host-microbiome communication, immunity and oxidative stress and the KP in turn is influenced by the microbiome environment. Age-associated decline in NAD+ is implicated as a driving factor in many age-associated diseases, including those seen in people with HIV (PWH). Recent studies have shown that KP can influence metabolic changes in PWH, including increased abdominal adiposity and cardiovascular disease. Furthermore, KP activity increases with age in the general population, but it is elevated in PWH at all ages compared to age-matched controls. Host or microbiome-mediated targeting of this pathway has merits to increase healthy longevity and has potential therapeutic applications in PWH.As a growing proportion of PWH age, many face increased risks of developing age-related comorbidities. Chronic inflammation, a pillar of geroscience, the science of ageing and of age-related disease, is influenced by the gut microbiome and its metabolites. Combined, these contribute to a systemic inflammatory signature. Advances in geroscience-based approaches and therapeutics offer a novel paradigm for addressing age-related diseases and chronic inflammation in HIV infection. Whether targeted inhibition of KP activity alleviates pathological conditions or promotes successful ageing in PWH remains to be determined.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据